BioSpace News Archive

Exblifep is a combination of a novel extended-spectrum beta-lactamase inhibitor, enmetazobactam, and the fourth-generation cephalosporin cefepime.

Under the license deal, RedHill is paying AstraZeneca $52.5 million up front with another non-contingent payment of $15 million 18 months after the deal closes.

The ASRS issued a note to its members about concerns regarding reports of vasculitis, an inflammation of the blood vessels and other complications that can lead to the loss of vision, as a potential side effect of treatment with Beovu.

Rising at an impressive single digit CAGR, the global polymerase chain reaction market is predicted to attain a value of almost US$7.0 bn by 2026-end.

Globally, increase cardiovascular diseases incidences and the increasing number of geriatric population that is susceptible to various chronic diseases have fueled growth in the global nitinol medical devices.

In recent years, the role of technology in the healthcare sector has become increasingly crucial.

The global structural biology and molecular modeling techniques market is a novel conception in the global healthcare sector and has already made key contributions in obtaining remedies to a number of diseases.

Komax Systems, Inc. a leader in advanced technology has been helping manufacturing companies from all over the world by providing them with the best static mixing technology.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored “Autism Together We Are Stronge

Bioclinica announced that Charles “Chuck” Bodner has joined the company as Executive Vice President, Chief Operating and Financial Officer.